Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1614-2023Class II

Codman Cranial Hand Drill- Indicated when a craniotomy is required for placement of an intracranial pressure...

Integra LifeSciences Corporation / initiated 2023-04-11 / Open, Classified

Integra LifeSciences Corp. began a recall of Codman Cranial Hand Drill- Indicated when a craniotomy is required for placement of an intracranial pressure (ICP) monitoring device and/or cerebrospinal fluid... on . FDA classified it as Class II and gives the reason as "Released with discoloration (rust) on the Drill Chuck and inner chuck of Codman Cranial Hand Drill may result in inflammation, local toxicity, systemic toxicity, sensitivity, revision surgery, procedural delay...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1614-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Integra LifeSciences Corporation
Product
Codman Cranial Hand Drill- Indicated when a craniotomy is required for placement of an intracranial pressure (ICP) monitoring device and/or cerebrospinal fluid drainage device. Part Number: 82-6607
Product code
GWM Device, Monitoring, Intracranial Pressure
Reason for recall
Released with discoloration (rust) on the Drill Chuck and inner chuck of Codman Cranial Hand Drill may result in inflammation, local toxicity, systemic toxicity, sensitivity, revision surgery, procedural delay, inconvenience to user, and/or infection.
FDA root cause
Under Investigation by firm
Action
Codman issued Urgent Medical Device Recall Letter on 4/11/23 via Fed'X. Letter states reason for recall, health risk and action to take: 1. If you do have units of the affected product listed in Table 1, remove them immediately from service. 2. If you do have affected product, check the box on the enclosed form I do have affected product. Record the total quantity of the affected product that you have. 3. If you do not have affected product, check the box, I do not have affected product. 4. Complete the attached Acknowledgement Form and return to [email protected] i. or FAX to 1-609-750-4220. 5. Keep a copy of the form for your records. 6. When your form is received, and it is noted that you have affected product, Customer Service will contact you and provide a Return Material Authorization (RMA) number and directions to return the affected product. A credit or alternative replacement can be placed for the quantity noted on the form. Receipt of this form ensures that Integra has achieved a level of effectiveness in communicating this information. We recommend you also maintain a copy of this notification and signed copy of the acknowledgement form for your records. Regulatory agencies such as the FDA perform audits of field actions of this nature to verify that customers have been notified and understand the nature of the field action. Should you have any questions regarding these instructions, please contact your Integra Sales Representative or Customer Service: Monday to Friday 8:00 AM 8:00 PM EST USA: 1-800-654-2873: email: [email protected]
Quantity in commerce
337 units
Distribution
PA Foreign: Australia, Belgium
Product codes and lots
UDI-DI: 10381780520337 Lot Numbers: 6808685, 6563961, 6568711, 6568709, 6568710

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1614-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1614-2023Class IIOngoingVoluntary: Firm initiated